About Micheal Lee Hebert, Ph.D.

Dr. Micheal Hebert counsels clients on strategies for maximizing intellectual property protection and leveraging that protection in several areas of life sciences. His practice includes drafting and prosecuting patent applications in genetics, gene therapy, personalized medicine, pharmaceuticals, virology, antibodies, stem cells, and microbiology. Micheal also has experience conducting due diligence research and analysis for freedom-to-operate investigations, patent validity opinions, patentability opinions, and technology licensing.

Micheal's practice also includes an emphasis on licensing and other commercial transactions in the life sciences. He assists clients in matters related to transfer of intellectual property rights and collaborations between parties, including drafting and negotiating license agreements and joint development agreements. He also performs due diligence assessments of transactions involving the acquisition and transfer of intellectual property rights.

Concentrations

•Life sciences and health care
•Patent portfolio management and strategic counseling
•IP due diligence
•Biotechnology

Recognition & Leadership

Awards & Accolades

•Listed, The Legal 500 United States, Healthcare Life Sciences, 2025
•Listed, The Best Lawyers in America, 'Ones to Watch,' 2021-2026
•Intellectual Property Law, 2025-2026
•Patent Law, 2025-2026
•Health Care Law, 2021-2024 and 2026
•Recipient, NIH, National Service Award, 2005
•Recipient, National Hemophilia Foundation Fellowship, 2006

 

Reviews for Micheal

This lawyer does not have any client reviews on Lawyers.com yet

Write a Review

Services

Areas of Law

  • Other 3
    • Intellectual Property & Technology
    • Patents and Innovation Strategies
    • Life Sciences & Medical Technology

Practice Details

  • Firm Information
    Position
    Shareholder
    Firm Name
    Greenberg Traurig, LLP
  • Representative Cases & Transactions
    Cases
    Experience: Representative Matters: Patent Prosecution
    Management - Managed
    /or drafted patent applications for over 100 products
    led patent prosecution
    coordinated IP support teams

    conducted numerous prior art searches
    reviews to strengthen patent applications.
    IP Due Diligence
    Defense - Defended clients' patent estates during 30+ IP due diligences for public offerings, financing or technology out-licensing
    provided written responses for numerous diligence requests

    supported diligence efforts on over 100 technologies.
    Strategic IP Analysis
    Opinions - Provided written opinions
    strategic guidance on third-party IP
    conducted patent reviews, preliminary opinions,
    developed invalidity claim charts
    offered guidance on projects analyzing the relevance of third-party IP
    inventorship disputes.
    Collaboration
    Coordination - Identified
    coordinated with internal
    external experts to enhance IP strategies
    outcomes.
    Internal
    External Training - Managed
    trained patent prosecution
    IP support teams with GT

    provided CLE
    training presentations on inventorship, subject matter eligibility, patent prosecution basics (35 USC 101, 112, 102
    103), double patenting,
    on-sale bar.
    Served as IP counsel in connection with the $84 million initial public offering of Hookipa Pharma Inc. (NASDAQ: HOOK).
    Represented Bellicum Pharmaceuticals, Inc. in the development
    prosecution of global patent portfolios related to cellular immuno-oncology (IO)
    immunotherapies, including BPX-601 (PSCA CAR-T)
    BPX-603 (Her2 CAR-T) clinical c
    idates utilizing the Bellicum's proprietary GoCAR technology.
    Represented NGM Biopharmaceuticals, Inc. in the development of a global patent portfolio for antibodies to beta-klotho for the treatment of diabetes
    other metabolic disorders.
    Represented Genomatica on a range of licensing
    joint development agreements with multiple partners worldwide.
    Assisted Hookipa Biotech AG in the development of a worldwide patent portfolio.
    Represents Genomatica in the development of a worldwide patent portfolio related to methods of producing high-volume basic
    intermediate chemicals from alternative feedstocks, such as sugars
    cellulosic biomass, using engineered microorganisms.
    Managed Genentech Inc.'s global patent portfolio
    prosecuted patent applications related to therapeutic antibodies.
    The above representations were h
    led by Dr. Hebert prior to his joining Greenberg Traurig, LLP.
    Previous Experience: Postdoctoral Fellow, Stanford University School of Medicine, 2005-2007
  • Additional Links

Experience

  • Bar Admission & Memberships
    Admissions
    registered to practice before the U.S. Patent and Trademark Office
    2015, California
  • Education & Certifications
    Law School
    University of San Diego School of Law
    Class of 2015
    J.D.
    Other Education
    State University of New York at Plattsburgh
    Class of 1998
    B.S.
    Cellular Biochemistry,

    University of Texas at Houston
    Class of 2005
    Ph.D.
    Human and Molecular Genetics

Contact Micheal Lee Hebert, Ph.D.

Share Holder at Greenberg Traurig, LLP
Not yet reviewed

12760 High Bluff Dr., Ste. 240San Diego, CA 92130U.S.A.

Show on map
Fax: 619-393-0877
949-732-6501
Case type is required.
A valid zip code is required.
A valid city is required.
State is required.
Country is required.
Outside the US or Canada?
Message is required.
0/1000 characters

Contact Information

First name is required.
Last name is required.
A valid email address is required.
A valid phone number is required.

By clicking the Submit button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Lawyers.com and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

Thank you! Your message has been successfully sent.

For your records, a copy of this email has been sent to

Summary of Your Message
Case Type:
Zip Code or Postal Code:
City:
State:
Country:
Case Description:
Contact Information
First Name:
Last Name:
Email:
Phone Number:

Attorneys FAQs

  • What year was this attorney first admitted to the bar?
    Micheal Lee Hebert, Ph.D. was admitted in 2015 to the State of California.
  • Is this attorney admitted to practice in any U.S. Federal Courts?
    Micheal Lee Hebert, Ph.D. is admitted to practice before the Patent Trial and Appeal Board.
  • How many attorneys are in this law firm?
    Greenberg Traurig, LLP has 2750 attorneys at this location.
  • What law school did this attorney attend?
    Micheal Lee Hebert, Ph.D. attended University of San Diego School of Law.
  • What year was this attorney's law firm established?
    Greenberg Traurig, LLP was established in 1967.